Scientists Explain How Existing Alzheimer’s Drug Clears Brain Plaques

Scientists have made a significant breakthrough in understanding how lecanemab, an FDA-approved Alzheimer's drug, effectively clears toxic amyloid plaques...

Scientists have made a significant breakthrough in understanding how lecanemab, an FDA-approved Alzheimer's drug, effectively clears toxic amyloid plaques...

A $2.8 million federal grant from the National Institutes of Health is funding continued research into a promising approach: computerized brain training...

Researchers at UCLA Health and UC San Francisco have identified a protein complex called CRL5SOCS4 that represents a natural Alzheimer's defense...

Brain volume data provides compelling evidence that oral Alzheimer's drugs can slow neurodegeneration in early-stage disease.

Catalyst MedTech announced on March 25, 2026 that it is establishing the full national deployment of its Full Access Neurology solution as the industry...

Congress has reintroduced the AADAPT Act (Accelerating Access to Dementia and Alzheimer's Provider Training), new bipartisan legislation designed to equip...

Yes, brief daily exercise can meaningfully improve brain health, according to recent scientific research.

The Brain Health Equity Initiative represents a coordinated effort to address one of healthcare's most pressing disparities: the disproportionate burden...

Brain stimulation therapy is emerging as a promising treatment approach for Alzheimer's disease, with recent clinical trials demonstrating measurable...

Scientists have identified specific types of brain cells that appear to resist Alzheimer's disease and slow its progression, revealing why some people's...